Hansa Biopharma AB (publ) (STO:HNSA)

Hansa Biopharma AB Revenue

Hansa Biopharma AB had revenue of 48.10M SEK in the quarter ending June 30, 2026, a decrease of -2.09%. This brings the company's total for the last twelve months to 189.46M, down -3.57% year-over-year. In the year 2025, Hansa Biopharma AB had annual revenue of 222.27M with 29.74% growth. That makes Hansa Biopharma AB the 34,056th largest company in the world by revenue and 444th in Sweden.

• Revenue (ttm): 189.46M
• Revenue Growth: -3.57%
• P/S Ratio: 21.13
• Revenue / Employee: 1.45M
• Employees: 131
• Market Cap: 3.85B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Europe (Ex Sweden) 202.28M 91.0%
• North America 14.09M 6.3%
• Rest of The World 5.90M 2.7%

Fiscal year ended Dec 31, 2025 See the full Hansa Biopharma AB breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	222.27M	50.95M	29.74%
Dec 31, 2024	171.32M	37.22M	27.76%
Dec 31, 2023	134.09M	-20.43M	-13.22%
Dec 31, 2022	154.53M	120.65M	356.12%
Dec 31, 2021	33.88M	27.78M	455.56%

Data Source: S&P Global Market Intelligence Last updated: Jul 22, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error